Healthcare provider profile · identity verified

Rupal S Oza, MD, MPH

Allopathic & Osteopathic Physicians|Family Medicine · COLUMBUS, OH · NPI 1760445027

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Rupal S Oza, MD, MPH received $205.85 in general payments during 2025 across 5 reported records.

ABBVIE INC. accounted for 59.3% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 4 associated products.

A separate comparison found the same explicitly named product in public Medicare Part D data: Nuplazid.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ARMOUR THYROID as an associated drug or biological on 50 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Armour Thyroid by this doctor in 2024.

ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Creon by this doctor in 2024.

ACADIA Pharmaceuticals Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUPLAZID as an associated drug or biological on 20845 records involving 6448 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Nuplazid by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$205.85

5 reported records · 4 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
ABBVIE INC.	Unresolved — no canonical attribution shown	$122.09	59.3%	1	2025
ACADIA Pharmaceuticals Inc	Unresolved — no canonical attribution shown	$37.87	18.4%	2	2025
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)	Unresolved — no canonical attribution shown	$24.41	11.9%	1	2025
Itamar Medical Inc	Unresolved — no canonical attribution shown	$21.48	10.4%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$205.85	5

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
UBRELVY Normalized: ubrelvy	Drug	ABBVIE INC.	$122.09	1	2025
Source payment records 2025-02-26 · ABBVIE INC. · $122.09 · Open Payments source
NUPLAZID Normalized: nuplazid	Drug	ACADIA Pharmaceuticals Inc	$37.87	2	2025
Source payment records 2025-08-13 · ACADIA Pharmaceuticals Inc · $17.10 · Open Payments source 2025-09-11 · ACADIA Pharmaceuticals Inc · $20.77 · Open Payments source
LifeVest Normalized: lifevest	Device	ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)	$24.41	1	2025
Source payment records 2025-06-12 · ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) · $24.41 · Open Payments source
WatchPATONE Normalized: watchpatone	Device	Itamar Medical Inc	$21.48	1	2025
Source payment records 2025-05-08 · Itamar Medical Inc · $21.48 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

Open Payments product	Payment year	Part D brand	Part D year	Claims	Match method	Source
NUPLAZID nuplazid	2025	Nuplazid	2024	26 Beneficiary count suppressed	exact normalized	Medicare Part D

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	ARMOUR THYROID open payments reported associated product	CMS Open Payments — General Payments 50 supporting records · 11 recipient NPIs · example record 1201517088	Armour Thyroid · 2024 Exact normalized brand match · 1 Part D row	15	suppressed by CMS
ABBVIE INC. Exact reporting entity; no affiliate inference	2025	CREON open payments reported associated product	CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608	Creon · 2024 Exact normalized brand match · 1 Part D row	23	suppressed by CMS
ACADIA Pharmaceuticals Inc Exact reporting entity; no affiliate inference	2025	NUPLAZID open payments reported associated product	CMS Open Payments — General Payments 20845 supporting records · 6448 recipient NPIs · example record 1247763852	Nuplazid · 2024 Exact normalized brand match · 1 Part D row	26	suppressed by CMS

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1427	224
Levothyroxine Sodium	Levothyroxine Sodium	1223	145
Eliquis	Apixaban	1108	124
Furosemide	Furosemide	1048	170
Gabapentin	Gabapentin	752	119
Potassium Chloride	Potassium Chloride	668	107
Amlodipine Besylate	Amlodipine Besylate	590	96
Sertraline Hcl	Sertraline Hcl	562	84
Metoprolol Succinate	Metoprolol Succinate	518	77
Metoprolol Tartrate	Metoprolol Tartrate	475	75
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	462	53
Lisinopril	Lisinopril	445	78
Pantoprazole Sodium	Pantoprazole Sodium	420	90
Donepezil Hcl	Donepezil Hcl	404	48
Carvedilol	Carvedilol	398	71
Clopidogrel	Clopidogrel Bisulfate	375	71
Mirtazapine	Mirtazapine	369	64
Trazodone Hcl	Trazodone Hcl	368	71
Metformin Hcl	Metformin Hcl	317	49
Tamsulosin Hcl	Tamsulosin Hcl	314	57
Buspirone Hcl	Buspirone Hcl	304	70
Losartan Potassium	Losartan Potassium	304	52
Famotidine	Famotidine	282	65
Omeprazole	Omeprazole	274	57
Duloxetine Hcl	Duloxetine Hcl	272	35
Levetiracetam	Levetiracetam	262	31
Spironolactone	Spironolactone	254	32
Memantine Hcl	Memantine Hcl	253	30
Myrbetriq	Mirabegron	238	21
Ropinirole Hcl	Ropinirole Hcl	226	29
Allopurinol	Allopurinol	213	35
Divalproex Sodium	Divalproex Sodium	201	34
Xarelto	Rivaroxaban	195	22
Escitalopram Oxalate	Escitalopram Oxalate	185	36
Citalopram Hbr	Citalopram Hydrobromide	179	33
Ondansetron Hcl	Ondansetron Hcl	177	84
Prednisone	Prednisone	164	44
Alendronate Sodium	Alendronate Sodium	161	20
Pravastatin Sodium	Pravastatin Sodium	149	22
Insulin Lispro Kwikpen U-100	Insulin Lispro	148	29
Quetiapine Fumarate	Quetiapine Fumarate	142	26
Januvia	Sitagliptin Phosphate	135	11
Hydroxyzine Hcl	Hydroxyzine Hcl	134	46
Hydralazine Hcl	Hydralazine Hcl	129	27
Hydrochlorothiazide	Hydrochlorothiazide	129	23
Latanoprost	Latanoprost	126	27
Amiodarone Hcl	Amiodarone Hcl	124	26
Cephalexin	Cephalexin	124	65
Meloxicam	Meloxicam	117	19
Oxybutynin Chloride Er	Oxybutynin Chloride	116	25
Tramadol Hcl	Tramadol Hcl	116	29
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	114	16
Simvastatin	Simvastatin	112	16
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	111	22
Fluticasone Propionate	Fluticasone Propionate	102	36
Isosorbide Mononitrate Er	Isosorbide Mononitrate	100	20
Topiramate	Topiramate	98	12
Doxycycline Hyclate	Doxycycline Hyclate	97	57
Farxiga	Dapagliflozin Propanediol	97	suppressed
Olanzapine	Olanzapine	96	12
Nystatin	Nystatin	95	46
Fluoxetine Hcl	Fluoxetine Hcl	94	19
Finasteride	Finasteride	92	19
Midodrine Hcl	Midodrine Hcl	91	28
Oxycodone Hcl	Oxycodone Hcl	91	26
Montelukast Sodium	Montelukast Sodium	89	13
Tizanidine Hcl	Tizanidine Hcl	82	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	81	27
Novolog Flexpen	Insulin Aspart	80	18
Warfarin Sodium	Warfarin Sodium	79	12
Risperidone	Risperidone	77	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	74	suppressed
Baclofen	Baclofen	71	20
Nifedipine Er	Nifedipine	71	20
Rosuvastatin Calcium	Rosuvastatin Calcium	70	13
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	68	27
Glimepiride	Glimepiride	66	12
Hydroxyzine Pamoate	Hydroxyzine Pamoate	66	22
Trulicity	Dulaglutide	66	12
Digoxin	Digoxin	65	suppressed
Lamotrigine	Lamotrigine	63	suppressed
Bupropion Xl	Bupropion Hcl	62	11
Enulose	Lactulose	62	12
Ezetimibe	Ezetimibe	61	14
Bupropion Hcl	Bupropion Hcl	59	suppressed
Torsemide	Torsemide	59	11
Sucralfate	Sucralfate	55	11
Venlafaxine Hcl Er	Venlafaxine Hcl	55	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	54	suppressed
Levofloxacin	Levofloxacin	54	29
Entresto	Sacubitril/Valsartan	53	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	52	26
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	52	22
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	52	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	51	12
Amantadine	Amantadine Hcl	48	suppressed
Jardiance	Empagliflozin	48	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	48	22
Paroxetine Hcl	Paroxetine Hcl	48	suppressed
Xifaxan	Rifaximin	48	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	47	45
Propranolol Hcl	Propranolol Hcl	46	suppressed
Albuterol Sulfate	Albuterol Sulfate	42	23
Ciprofloxacin Hcl	Ciprofloxacin Hcl	42	26
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	16
Insulin Aspart Flexpen	Insulin Aspart	41	18
Ondansetron Odt	Ondansetron	41	31
Clonidine Hcl	Clonidine Hcl	40	12
Primidone	Primidone	40	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	40	21
Carbamazepine	Carbamazepine	39	suppressed
Diclofenac Sodium	Diclofenac Sodium	39	18
Aripiprazole	Aripiprazole	38	suppressed
Humalog Kwikpen U-100	Insulin Lispro	38	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	38	suppressed
Azithromycin	Azithromycin	37	17
Humulin N Kwikpen	Insulin Nph Human Isophane	37	suppressed
Tresiba Flextouch U-100	Insulin Degludec	37	suppressed
Valproic Acid	Valproic Acid	36	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	36	suppressed
Atenolol	Atenolol	35	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	35	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	35	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	13
Fiasp Flextouch	Insulin Aspart (Niacinamide)	34	suppressed
Gemtesa	Vibegron	33	suppressed
Scopolamine	Scopolamine	33	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	32	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	31	27
Admelog Solostar	Insulin Lispro	31	suppressed
Benztropine Mesylate	Benztropine Mesylate	31	suppressed
Cilostazol	Cilostazol	31	suppressed
Flecainide Acetate	Flecainide Acetate	31	suppressed
Glipizide	Glipizide	31	suppressed
Incruse Ellipta	Umeclidinium Bromide	31	suppressed
Ammonium Lactate	Ammonium Lactate	30	17
Brimonidine Tartrate	Brimonidine Tartrate	29	suppressed
Celecoxib	Celecoxib	29	suppressed
Cholestyramine	Cholestyramine (With Sugar)	29	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	29	12
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	28	suppressed
Breo Ellipta	Fluticasone/Vilanterol	27	suppressed
Calcitriol	Calcitriol	27	suppressed
Divalproex Sodium Er	Divalproex Sodium	27	suppressed
Fluconazole	Fluconazole	27	21
Memantine Hcl Er	Memantine Hcl	27	suppressed
Metolazone	Metolazone	27	suppressed
Bumetanide	Bumetanide	26	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Hydrocortisone	Hydrocortisone	26	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	26	suppressed
Movantik	Naloxegol Oxalate	26	suppressed
Nuplazid	Pimavanserin Tartrate	26	suppressed
Prednisolone Acetate	Prednisolone Acetate	26	suppressed
Amoxicillin	Amoxicillin	25	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	25	suppressed
Pregabalin	Pregabalin	25	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Mirabegron Er	Mirabegron	24	12
Valsartan	Valsartan	24	suppressed
Creon	Lipase/Protease/Amylase	23	suppressed
Imipramine Hcl	Imipramine Hcl	23	suppressed
Insulin Degludec Pen (U-100)	Insulin Degludec	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	23	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	23	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	23	suppressed
Terazosin Hcl	Terazosin Hcl	23	suppressed
Alprazolam	Alprazolam	22	suppressed
Diltiazem Hcl	Diltiazem Hcl	22	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Labetalol Hcl	Labetalol Hcl	22	suppressed
Methotrexate	Methotrexate Sodium	22	suppressed
Prazosin Hcl	Prazosin Hcl	22	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	21	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	21	suppressed
Nitroglycerin	Nitroglycerin	21	17
Dapagliflozin	Dapagliflozin Propanediol	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Lubiprostone	Lubiprostone	20	suppressed
Atropine Sulfate	Atropine Sulfate	19	suppressed
Restasis	Cyclosporine	19	suppressed
Veltassa	Patiromer Calcium Sorbitex	19	suppressed
Anastrozole	Anastrozole	18	suppressed
Clozapine	Clozapine	18	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	18	suppressed
Sodium Chloride	0.9 % Sodium Chloride	18	suppressed
Trimethoprim	Trimethoprim	18	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	18	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Ranolazine Er	Ranolazine	16	suppressed
Acetic Acid	Acetic Acid	15	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	15	suppressed
Armour Thyroid	Thyroid,pork	15	suppressed
Caplyta	Lumateperone Tosylate	15	suppressed
Combigan	Brimonidine Tartrate/Timolol	15	suppressed
Dexamethasone	Dexamethasone	15	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	15	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	15	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Breyna	Budesonide/Formoterol Fumarate	14	suppressed
Brilinta	Ticagrelor	14	suppressed
Cefdinir	Cefdinir	14	11
Diltiazem 12hr Er	Diltiazem Hcl	14	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	14	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	14	12
Ketoconazole	Ketoconazole	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Nyamyc	Nystatin	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Insulin Lispro	Insulin Lispro	13	suppressed
Nadolol	Nadolol	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Vilazodone Hcl	Vilazodone Hcl	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Felodipine Er	Felodipine	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Lactulose	Lactulose	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Zonisamide	Zonisamide	12	suppressed
Budesonide	Budesonide	11	suppressed
Cimetidine	Cimetidine	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	11	suppressed
Haloperidol Lactate	Haloperidol Lactate	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Phenytoin	Phenytoin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$205.85 · 5 records	ABBVIE INC.	LifeVest, NUPLAZID, UBRELVY, WatchPATONE	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

What role, if any, does Nuplazid play in your treatment recommendations for me?
How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error